Related Experiment Video
Updated: Jun 4, 2026

Isolation of Murine Peritoneal Macrophages to Carry Out Gene Expression Analysis Upon Toll-like Receptors Stimulation
Published on: April 29, 2015
Alternative activation of macrophages in human peritoneum: implications for peritoneal fibrosis
Teresa Bellón1, Virginia Martínez, Baltasar Lucendo
1Research Unit, Hospital Universitario La Paz-FIBHULP, Madrid, Spain. tbellon.hulp@salud.madrid.org
Background:
Depending on the cytokine microenvironment, macrophages (Mϕ) can adopt a proinflammatory (M1) or a profibrotic (M2) phenotype characterized by the expression of cell surface proteins such as CD206 and CD163 and soluble factors such as CC chemokine ligand 18 (CCL18). A key role for Mϕ in fibrosis has been observed in diverse organ settings. We studied the Mϕ population in a human model of peritoneal dialysis in which continuous stress due to dialysis fluids and recurrent peritonitis represent a risk for peritoneal membrane dysfunction reflected as ultrafiltration failure (UFF) and peritoneal fibrosis.
Methods:
We used flow cytometry and quantitative reverse transcription-polymerase chain reaction to analyse the phenotype of peritoneal effluent Mϕ and tested their ability to stimulate the proliferation of human fibroblasts. Mϕ from non-infected patients were compared with those from patients with active peritonitis. Cytokine production was evaluated by enzyme-linked immunosorbent assay (ELISA) in spent dialysates and cell culture supernatants.
Results:
CD206(+) and CD163(+) M2 were found within peritoneal effluents by flow cytometry analysis, with increased frequencies of CD163(+) cells during peritonitis (P = 0.003). TGFB1, MMP9 and CCL18 messenger RNA (mRNA) levels in peritoneal macrophages (pMϕ) were similar to those found in M2 cells differentiated in vitro. The ability of pMϕ to stimulate fibroblast proliferation correlated with CCL18 mRNA levels (r = 0.924, P = 0.016). CCL18 production by pMϕ was confirmed by immunostaining of cytospin samples and ELISA. Moreover, CCL18 effluent concentrations correlated with decreased peritoneal function, which was evaluated as dialysate to plasma ratio of creatinine (r = 0.724, P < 0.0001), and were significantly higher in patients with UFF (P = 0.0025) and in those who later developed sclerosing peritonitis (P = 0.024).
Conclusions:
M2 may participate in human peritoneal fibrosis through the stimulation of fibroblast cell growth and CCL18 production as high concentrations of CCL18 are associated with functional deficiency and fibrosis of the peritoneal membrane.
Insights
Macrophages (Mϕ) adopt profibrotic (M2) phenotypes, expressing CD163 and producing CC chemokine ligand 18 (CCL18). Elevated CCL18 in peritoneal dialysis patients correlates with peritoneal membrane dysfunction and fibrosis.
Area of Science:
- Immunology
- Cell Biology
- Nephrology
Background:
- Macrophages (Mϕ) exhibit proinflammatory (M1) or profibrotic (M2) phenotypes based on the cytokine microenvironment.
- M2 macrophages express CD206 and CD163, and secrete factors like CC chemokine ligand 18 (CCL18).
- Peritoneal dialysis patients face risks of peritoneal membrane dysfunction, ultrafiltration failure (UFF), and fibrosis due to continuous stress and peritonitis.
Purpose of the Study:
- To investigate the role of Mϕ phenotypes in peritoneal fibrosis in patients undergoing peritoneal dialysis.
- To analyze the characteristics and functional capacity of peritoneal effluent Mϕ.
- To determine the association between Mϕ phenotype, CCL18 production, and peritoneal membrane function.
Main Methods:
- Flow cytometry and quantitative reverse transcription-polymerase chain reaction (qRT-PCR) were used to analyze peritoneal effluent Mϕ phenotype.
- Fibroblast proliferation assays were performed to assess Mϕ's ability to stimulate fibroblast growth.
- Cytokine production was measured using enzyme-linked immunosorbent assay (ELISA) and immunostaining.
Main Results:
- Increased frequencies of CD163+ M2 macrophages were observed during peritonitis.
- Peritoneal macrophages (pMϕ) exhibited M2-like characteristics, including CCL18 mRNA expression.
- pMϕ-stimulated fibroblast proliferation correlated with CCL18 mRNA levels (r = 0.924, P = 0.016).
- CCL18 effluent concentrations were linked to decreased peritoneal function (r = 0.724, P < 0.0001) and were higher in patients with UFF and those who developed sclerosing peritonitis.
Conclusions:
- M2 macrophages may contribute to human peritoneal fibrosis by promoting fibroblast proliferation and producing CCL18.
- High concentrations of CCL18 are associated with impaired peritoneal membrane function and fibrosis.
- Targeting M2 macrophages or CCL18 could be a therapeutic strategy for peritoneal dialysis-associated fibrosis.
Related Concept Videos
Chronic Inflammation: Introduction
Cirrhosis II: Pathophysiology
